快速多重PCR面板在慢阻肺急性加重住院成人中的真实世界评估
这项前瞻性观察研究纳入74例慢阻肺急性加重住院患者,用BioFire FilmArray肺炎加面板(FAPP)检测自发痰,并与标准检测(SOC)比较。FAPP将可识别病原体比例从36%提高到78%(p<0.0001),细菌检出增加47%(p<0.0001),周转时间中位6小时对75小时(p<0.0001);细菌为主表型与更高急性加重严重度相关,纯嗜酸性表型180天治疗失败率低于未分类表型。
要点
- FAPP将慢阻肺急性加重患者痰病原体检出比例从36%提高到78%。
- FAPP细菌检出增加47%,周转时间中位6小时,显著短于SOC的75小时。
- 细菌为主表型与更高急性加重严重度相关,纯嗜酸性表型180天治疗失败率更低。
核心结论
- FAPP显著提高慢阻肺急性加重住院患者痰标本的微生物检出率,并可能辅助抗生素决策与表型分型。
研究设计与样本
- 前瞻性观察研究,纳入74例慢阻肺急性加重住院患者,比较FAPP与标准检测对自发痰的检测结果。
主要发现
- FAPP将可识别病原体比例从SOC的36%提高到78%(增加42%,p<0.0001)。
- 细菌检出增加47%(p<0.0001),FAPP周转时间中位6小时,SOC中位75小时(p<0.0001)。
- 金黄色葡萄球菌最常见,流感嗜血杆菌在高丰度(106-≥107 copies/ml)时占优;呼吸道病毒检出27%,甲型流感最常见。
- FAPP在高丰度下与所有面板内培养细菌一致检出;高丰度细菌检出与显著更高的宿主免疫反应标志物相关。
- 细菌为主表型与更高急性加重严重度相关;纯嗜酸性表型180天治疗失败率低于未分类表型。
临床怎么用
- 可考虑用FAPP检测慢阻肺急性加重住院患者痰标本,以更快获得病原学结果并辅助抗生素决策。
- 可依据FAPP结果进行表型分型,关注细菌为主表型与纯嗜酸性表型的临床差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The clinical utility of rapid multiplex PCR panels in patients with exacerbation of COPD (ECOPD) is undefined. We aimed to assess the clinical relevance of the BioFire FilmArray pneumonia plus panel (FAPP) testing in ECOPD in a real-world hospital setting. METHODS: A prospective observational study was conducted on 74 hospitalized ECOPD patients. Spontaneous sputum samples were analysed using FAPP alongside standard-of-care (SOC) tests. Microbial profiles were assessed, and patients were phenotyped based on FAPP findings. RESULTS: FAPP significantly increased the proportion of patients with identifiable pathogens from 36% by SOC tests to 78% (increase of 42%, p < 0.0001), primarily contributed by increased bacterial detection (increase of 47%, p < 0.0001), with a shorter turnaround time (median 6 h vs. 75 h, p < 0.0001). Staphylococcus aureus was the most prevalent bacteria, while Haemophilus influenzae predominated at high abundance (106-≥ 107 copies/ml). Respiratory viruses were detected in 27%, most frequently Influenza A. All in-panel cultured bacteria were concordantly detected by FAPP at high abundance. High-abundance bacterial detection was associated with significantly higher host immune response markers. The bacterial-predominant phenotype was associated with higher exacerbation severity, while the purely eosinophilic phenotype had a lower 180-day treatment failure rate compared to the unclassified phenotype. CONCLUSION: FAPP significantly enhances microbial detection in patients with ECOPD. Appropriate utilization of FAPP might guide antibiotic decision-making and phenotyping in ECOPD. The potential of sputum multiplex PCR-based strategy to guide antibiotic decisions in ECOPD merits further research.
引用
- Wong, Lam, Yew, et al. Real-World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbations. Respirology. 2026. PMID: 41891127. doi:10.1002/resp.70242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。